Related references
Note: Only part of the references are listed.Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer
Daniel A. Galvao et al.
BJU INTERNATIONAL (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Physical function changes in prostate cancer patients on androgen deprivation therapy: A 2-year prospective study
Matthew E. Levy et al.
UROLOGY (2008)
Is Src the key to understanding metastasis and developing new treatments for colon cancer?
Jiezhong Chen
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2008)
Endocrine and immune responses to resistance training in prostate cancer patients
D. A. Galvao et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2008)
Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer
D. A. Galvao et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2007)
Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality
Henry K. Tsai et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer
Christopher S. Saigal et al.
CANCER (2007)
Physical function in men with prostate cancer on androgen deprivation therapy
Cheryl A. Clay et al.
PHYSICAL THERAPY (2007)
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions
Anthony V. D'Amico et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Resistance training and reduction of treatment side effects in prostate cancer patients
Daniel A. Galvao et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2006)
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Nancy L. Keating et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability
AB Newman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Insulin sensitivity during combined androgen blockade for prostate cancer
MR Smith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Estimating cardiorespiratory fitness in well-functioning older adults: Treadmill validation of the Long Distance Corridor Walk
EM Simonsick et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2006)
Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer
MR Smith et al.
JOURNAL OF UROLOGY (2006)
Quality of life, morbidity, and mortality after low trauma hip fracture in men
I Pande et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer
SL Greenspan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Resistance exercise dosage in older adults: Single-versus multiset effects on physical performance and body composition
DA Galvao et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma
H Lee et al.
CANCER (2005)
Osteoporosis during androgen deprivation therapy for prostate cancer
MR Smith
UROLOGY (2002)
Long-term effects of androgen deprivation therapy in prostate cancer patients
S Basaria et al.
CLINICAL ENDOCRINOLOGY (2002)
Exercise capacity and mortality among men referred for exercise testing
J Myers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Changes in body composition during androgen deprivation therapy for prostate cancer
MR Smith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Measuring fitness in healthy older adults: The health ABC long distance corridor walk
EM Simonsick et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2001)